Hematology & Oncology Doctors in Weston, FL Accepting Medicare

8 Hematology & Oncology doctors found. Showing 1 - 8

Dr. Stephen Garrett Marcus, M.D. Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 1792 Bell Tower Ln, Weston, FL 33326 Phone: 954-315-3660    Fax: 954-315-3661

Dr. Chakra Pani Chaulagain, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2950 Cleveland Clinic Blvd, Weston, FL 33331 Phone: 954-659-5840    Fax: 954-659-5810

Evan W Alley, MD, PHD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2950 Cleveland Clinic Blvd, Weston, FL 33331 Phone: 954-659-5840    Fax: 954-659-5810

Dr. Diana Saravia, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2950 Cleveland Clinic Blvd, Weston, FL 33331 Phone: 954-659-5000

Tiffany George, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2950 Cleveland Clinic Blvd, Weston, FL 33331 Phone: 954-659-5000

Dr. Arun Nagarajan, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2950 Cleveland Clinic Blvd, Weston, FL 33331 Phone: 954-659-5840    Fax: 954-659-5833

Chieh-lin Fu, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2950 Cleveland Clinic Blvd, Weston, FL 33331 Phone: 954-659-5000    Fax: 954-659-5810

Chebli Mrad, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2950 Cleveland Clinic Blvd, Weston, FL 33331 Phone: 877-463-2010

News Archive

New protocol for reducing the use of SPECT SPI is found to be diagnostically safe

A new stress test protocol that investigates reducing the use of perfusion imaging in low risk patients undergoing SPECT myocardial perfusion imaging for possible angina symptoms was found to be diagnostically safe, revealed a US retrospective analysis.

FDA accepts Eisai's resubmission of perampanel NDA for review

Eisai Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted for review Eisai's resubmission of the New Drug Application (NDA) for perampanel (E2007), an investigational drug, for the treatment of partial-onset seizures associated with epilepsy.

First genetic test on developing risk of Alzheimer's disease and heart attacks

Alzheimer and heart attacks have been found to share common genetic basis. The research leads the way to the first genetic test on developing the risk of the diseases even at a young age. According to Federico Licastro, an immunologist at the University of Bologna who coordinated the study published in the scientific journal, Journal of Alzheimer's Disease, a test is now ready. "They are already selling it in America", he says, citing the case of a private firm in New Mexico (USA) that collaborated on the study. "But the tests could easily be also conducted wherever, using a simple blood test".

Young Faces of ALS campaign to raise awareness on ALS

The ALS Therapy Development Institute announced today that it is supporting a new awareness campaign driven by several ALS patients diagnosed with the progressive neurodegenerative disease commonly known as Lou Gehrig's disease before the age of 30. This campaign, called "Young Faces of ALS," is designed and led by a group of seven young men and women and will consist of a group effort to visit each of the 30 Major League Baseball parks during the 2010 baseball season.

Read more Medical News

› Verified 5 days ago